Gendo Y, Matsumoto T, Kamiyama N, Saechue B, Fukuda C, Dewayani A, Hidano S, Noguchi K, Sonoda A, Ozaki T, Sachi N, Hirose H, Ozaka S, Eshita Y, Mizukami K, Okimoto T, Kodama M, Yoshimatsu T, Nishida H, Daa T, Yamaoka Y, Murakami K, Kobayashi T
Dysbiosis of the Gut Microbiota on the Inflammatory Background due to Lack of Suppressor of Cytokine Signalling-1 in Mice.
Inflamm Intest Dis. 3(3), 145-154, 2019

Harada H, Suehiro S, Murakami D, Nakahara R, Nagasaka T, Ujihara T, Sagami R, Katsuyama Y, Hayasaka K, Amano Y.
Feasibility of gastric endoscopic submucosal dissection with continuous low-dose aspirin for patients receiving dual antiplatelet therapy.
World J Gastroenterol. Jan 28 25(4), 457-468, 2019

Kodama K, Kawaguchi T, Hyogo H, Nakajima T, Ono M, Seike M, Takahashi H, Nozaki Y, Kawanaka M, Tanaka S, Imajo K, Sumida Y, Kamada Y, Fujii H, Seko Y, Takehara T, Itoh Y, Nakajima A, Masaki N, Torimura T, Saibara T, Karino Y, Chayama K, Tokushige K.
Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosis.
J Gastroenterol Hepatol, 2019 Sep;34(9):1626-1632

Tateishi R, Seike M, Kudo M, Tamai H, Kawazoe S, Katsube T, Ochiai T, Fukuhara T, Kano T, Tanaka K, Kurokawa M, Yamamoto K, Osaki Y, Izumi N, Imawari M.
A randomized controlled trial of lusutrombopag in Japanese patients with chronic liver disease undergoing radiofrequency ablation.
J Gastroenterol, 54(2), 171-181, 2019.Feb

Mizukami K, Matsunari O, Ogawa R, Hirashita Y, Okamoto K, Fukuda K, Sonoda A, Akiyama H, Ozaka S, Kawahara Y, Okimoto T, Kodama M, Murakami K.
Examine the Availability and Safety of Mucosal Cutting Biopsy Technique for Diagnosis of Gastric Submucosal Tumor.
Gastroenterol Res Pract, 2019(Article ID 3121695), 2019.May




Fukuda M, Ishigaki H, Sugimoto M, Mukaisho K, Matsubara A, Ishida H, Moritani S, Itoh Y, Sugihara H, Andoh A, Ogasawara K, Murakami K, Kushima R.
Histological analysis of fundic gland polyps secondary to PPI therapy.
Histopathology. 2019. Oct;75(4):537-545. doi: 10.1111/his.13902. Epub 2019 Aug 2.

Kawahara Y, Kodama M, Mizukami K, Saito T, Hirashita Y, Sonoda A, Fukuda K, Matsunari O, Okamoto K, Ogawa R, Okimoto T, Murakami K.
Endoscopic gastric mucosal atrophy as a predictor of colorectal polyps: a large scale case-control study
Journal of Clinical Biochemistry and Nutrition.
2019 Sep;65(2):153-159. doi: 10.3164/jcbn.19-47. Epub 2019 Aug 23.

Kodama M, Okimoto T, Mizukami K, Fukuda K, Ogawa R, Okamoto K, Matsunari O, Kawahara Y, Hirashita Y, Murakami K.
Differences in Helicobacter pylori and CagA antibody changes after eradication between subjects developing and not developing gastric Evalution.

1. Clin. Biochem. Nutr, 2019 Jul ;65(1), 71-75, doi: 10.3164/jcbn.19-30. Epub 2019 Jun 11.

Abe T, Kusatsu K, Nagai T, Murakami K.
Successful endoscopic retrieval of a toothpick stuck in the small intestine using double-balloon enteroscopy.
Endoscopy. 2019 Sep 9. doi: 10.1055/a-0992-8959. [Epub ahead of print] No abstract available.　　PMID: 31499533

Wada K, Ueo T, Yonemasu H, Togo K, Inoue S, Honda H, Katsuta M, Takahashi H, Yao K, Murakami K.
Antacids may increase the appearance of white opaque substance in Helicobacter pylori -eradicated gastric epithelial neoplasia.
Endosc Int Open. 2019 Sep;7(9):E1144-E1149. doi: 10.1055/a-0961-7916. Epub 2019 Aug 29. PMID: 31475233 Free PMC Article

Kodama M, Okimoto T, Mizukami K, Fukuda K, Ogawa R, Okamoto K, Matsunari O, Wada Y, Hirashita Y, Murakami K.
Evaluation of a Novel Anti-H. pylori Antibody Detection Kit by Latex Turbidimetric Immunoassay.
Clin Lab. 2019 Jun 1;65(6). doi: 10.7754/Clin.Lab.2018.180918. PMID: 31232019

Deguchi H, Uda A, Murakami K.
Current Status of Helicobacter pylori Diagnosis and Eradication Therapy in Japan Using a Nationwide Database.
Digestion. 2019 Jun 19:1-9. doi: 10.1159/000500819. [Epub ahead of print]
PMID: 31216549

Kato M, Ota H, Okuda M, Kikuchi S, Satoh K, Shimoyama T, Suzuki H, Handa O, Furuta T, Mabe K, Murakami K, Sugiyama T, Uemura N, Takahashi S.
Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition.
Helicobacter. 2019 Aug;24(4):e12597. doi: 10.1111/hel.12597. Epub 2019 May 20.
PMID: 31111585

Ansari S, Akada J, Matsuo Y, Shiota S, Kudo Y, Okimoto T, Murakami K, Yamaoka Y.
Epitope peptides of Helicobacter pylori CagA antibodies from sera by whole-peptide mapping.
J Gastroenterol. 2019 Dec; 54(12):1039-1051. doi: 10.1007/s00535-019-01584-8. Epub 2019 May 2.
PMID:31049715

Fukuda M, Miyake T, Matsubara A, Ikai N, Tanaka E, Namura T, Wada Y, Noujima M, Moritani S, Murakami K, Andoh A, Tani M, Kushima R.
A Case of Sclerosing Mesenteritis Mimicking IgG4-related Disease.
Intern Med Advance Publication. 2019 Nov 8. DOI:10.2169/internalmedicine 3221-19
[Epub ahead of print]
PMID: 31708540

Fukuda M, Ishigaki H, Sugimoto M, Mukaisho K, Matsubara A, Ishida H, Moritani S, Itoh Y, Sugihara H, Andoh A, Ogasawara K, Murakami K, Kushima R.
Histological analysis of fundic gland polyps secondary to PPI therapy
Histropathology 2019 Oct, 75(4), 537-545. DOI: 10.1111/his.13902
PMID: 31087669

Sonoda A, Wada Y, Togo K, Mizukami K, Fuyuno Y, Umeno J, Fujioka S, Fukuda K, Okamoto K, Ogawa R, Okimoto T, Murakami K.
Characteristic Facial Appearance Was the Key to Diagnosing Chronic Enteropathy Associated with SLCO2A1-Associated Primary Hypertrophic Osteoarthropathy: A Case Report.
Intern Med. 2019 Oct 15. doi: 10.2169/internalmedicine.3369-19. [Epub ahead of print]
PMID:31611528

Iida A, Kuranuki S, Yamamoto R, Uchida M, Ohta M, Ichimura M, Tsuneyama K, Masaki T, Seike M, Nakamura T
Analysis of amino acid profiles of blood over time and biomarkers associated with non-alcoholic steatohepatitis in STAM mice.
Exp Anim. 2019 Nov 6;68(4):417-428. doi: 10.1538/expanim.18-0152. Epub 2019 Jun 1.
PMID:31155606

Nakano M, Koga H, Ide T, Kuromatsu R, Hashimoto S, Yatsuhashi H, Seike M, Higuchi N, Nakamuta M, Shakado S, Sakisaka S, Miuma S, Nakao K, Yoshimaru Y, Sasaki Y, Oeda S, Eguchi Y, Honma Y, Harada M, Nagata K, Mawatari S, Ido A, Maeshiro T, Matsumoto S, Takami Y, Sohda T, Torimura T
Predictors of hepatocellular carcinoma recurrence associated with the use of direct-acting antiviral agent therapy for hepatitis C virus after curative treatment: A prospective multicenter cohort study.
Cancer Med. 2019 May;8(5):2646-2653. doi: 10.1002/cam4.2061. Epub 2019 Mar 22.
PMID:30900818

Ide T, Koga H, Nakano M, Hashimoto S, Yatsuhashi H, Higuchi N, Nakamuta M, Oeda S, Seike M, Maeshiro T, Miuma S, Nakao K, Mawatari S, Ido A, Nagata K, Matsumoto S, Takami Y, Sohda T, Kakuma T, Torimura T.
Direct-acting antiviral agents do not increase the incidence of hepatocellular carcinoma development: a prospective, multicenter study.
Hepatol Int. 2019 May;13(3):293-301. doi: 10.1007/s12072-019-09939-2. Epub 2019 Feb 28.

Hitomi Y, Ueno K, Kawai Y, Nishida N, Kojima K, , Kawashima M, Aiba Y, Nakamura H, Seike M, Nakamura M et al.
POGLUT1, the putative effector gene driven by rs2293370 in primary biliary cholangitis susceptibility locus chromosome 3q13.33.
Sci Rep. 2019 Jan 14;9(1):102. doi: 10.1038/s41598-018-36490-1.
PMID:30643196

Hidaka H, Kurosaki M, Tanaka H, Kudo M, Abiru S, Seike M, KatsIzumi N, Imawari M et.al.
Lusutrombopag Reduces Need for Platelet Transfusion in Patients With Thrombocytopenia Undergoing Invasive Procedures.
Clin Gastroenterol Hepatol. 2019 May;17(6):1192-1200. doi: 10.1016/j.cgh.2018.11.047. Epub 2018 Nov 28.
PMID:30502505

Tateishi R, Uchino K, Fujiwara N, Takehara T, Okanoue T, Seike M, Yoshiji H, Yatsuhashi H, Shimizu M, Torimura T, Moriyama M, Sakaida I, Okada H, Chiba T, Chuma M, Nakao K, Isomoto H, Sasaki Y, Kaneko S, Masaki T, Chayama K, Koike K.
A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011-2015 update.
J Gastroenterol. 2019 Apr;54(4):367-376. doi: 10.1007/s00535-018-1532-5. Epub 2018 Nov 29.
PMID:30498904

Saito Y, Imamura M, Uchida T, Osawa M, Teraoka Y, Fujino H, Nakahara T, Ono A, Murakami E, Kawaoka T, Miki D1,2, Tsuge M, Serikawa M, Aikata H, Abe-Chayama H, Hayes CN, Chayama K
Ribavirin induces hepatitis C virus genome mutations in chronic hepatitis patients who failed to respond to prior daclatasvir plus asunaprevir therapy.
J Med Virol. 2019 Oct 4. doi: 10.1002/jmv.25602. [Epub ahead of print]

（内田宅郎先生より）
Osawa M, Uchida T, Imamura M, Teraoka Y, Fujino H, Nakahara T, Ono A, Murakami E, Kawaoka T, Miki D, Tsuge M Hiramatsu A, Abe-Chayama H, Hayes CN, Makokha GN, Aikata H, Ishida Y, Tateno C, Miyayama Y, Hijikata M, Chayama K.
Efficacy of glecaprevir and pibrentasvir treatment for genotype 1b hepatitis C virus drug resistance-associated variants in humanized mice.
J Gen Virol. 2019 Jul;100(7):1123-1131. doi: 10.1099/jgv.0.001268. Epub 2019 Jun 14.

Makokha GN, Abe-Chayama H, Chowdhury S, Hayes CN, Tsuge M, Yoshima T, Ishida Y, Zhang Y, Uchida T, Tateno C, Akiyama R, Chayama K.
Regulation of the Hepatitis B virus replication and gene expression by the multi-functional protein TARDBP.
Sci Rep. 2019 Jun 11;9(1):8462. doi: 10.1038/s41598-019-44934-5.

Tsuge M, Uchida T, Walsh K, Ishida Y, Tateno C, Kumar U, Glenn JS, Koh C, Heller T, Uprichard SL, Dahari H, Chayama K.
Early Multiphasic HBV Infection Initiation Kinetics Is Not Clone-Specific and Is Not Affected by Hepatitis D Virus (HDV) Infection.
Viruses. 2019 Mar 15;11(3). pii: E263. doi: 10.3390/v11030263.

Hamdane N, Jühling F, Crouchet E, El Saghire H, Thumann C, Oudot MA, Bandiera S, Saviano A, Ponsolles C, Roca Suarez AA, Li S, Fujiwara N, Ono A, Davidson I, Bardeesy N, Schmidl C, Bock C, Schuster C, Lupberger J, Habersetzer F, Doffoël M, Piardi T, Sommacale D, Imamura M, Uchida T, Ohdan H, Aikata H, Chayama K, Boldanova T, Pessaux P, Fuchs BC, Hoshida Y, Zeisel MB, Duong FHT, Baumert TF.
HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response.
Gastroenterology. 2019 Jun;156(8):2313-2329.e7. doi: 10.1053/j.gastro.2019.02.038. Epub 2019 Mar 2.

（内田宅郎先生より）
Tsushima K, Tsuge M, Hiraga N, Uchida T, Murakami E, Makokha GN, Kurihara M, Nomura M, Hiyama Y, Fujino H, Ono A, Nakahara T, Yamauchi M, Abe-Chayama H, Kawaoka T, Miki D, Imamura M, Aikata H, Hayes CN, Chayama K.
Comparison of intracellular responses between HBV genotype A and C infection in human hepatocyte chimeric mice.
J Gastroenterol. 2019 Jul;54(7):650-659. doi: 10.1007/s00535-019-01558-w. Epub 2019 Feb 21.
Tatsukawa Y, Tsuge M, Kawakami Y, Hiyama Y, Murakami E, Kurihara M, Nomura M, Tsushima K, Uchida T, Nakahara T, Miki D, Kawaoka T, Abe-Chayama H, Imamura M, Aikata H, Ochi H, Hayes CN, Kawakami H, Chayama K.
Correction: Reduction of hepatitis B surface antigen in sequential versus add-on pegylated interferon to nucleoside/nucleotide analogue therapy in HBe-antigen-negative chronic hepatitis B patients: a pilot study.
Antivir Ther. 2019;23(8):709. doi: 10.3851/IMP3289.

Osawa M, Imamura M, Teraoka Y, Uchida T, Morio K, Fujino H, Nakahara T, Ono A, Murakami E, Kawaoka T, Miki D, Tsuge M, Hiramatsu A, Aikata H, Hayes CN, Chayama K; Hiroshima Liver Study Group.
Real-world efficacy of glecaprevir plus pibrentasvir for chronic hepatitis C patient with previous direct-acting antiviral therapy failures.
J Gastroenterol. 2019 Mar;54(3):291-296. 2019 10.1007/s00535-018-1520-9

（新別府病院　香川先生より）
Efficacy of vonoprazan for initial and maintenance therapy in reflux esophagitis, nonerosive esophagitis, and proton pump inhibitor-resistant gastroesophageal reflux disease
Gotoh, Yasuhiko MDa,∗; Ishibashi, Emiko MDa; Honda, Shunichiro MDa; Nakaya, Tomohisa MDa; Noguchi, Chishio MDa; Kagawa, Koichi MD, PhDa; Murakami, Kazunari MD, PhDbSection Editor(s): Mayr., Johannes
Medicine: March 2020 - Volume 99 - Issue 11 - p e19520
doi: 10.1097/MD.0000000000019520

（大分三愛メディカルセンター　錦織先生より）
Clinical efficacy and safety of endoscopic ultrasound-guided gallbladder drainage replacement of percutaneous drainage: A multicenter retrospective study.
Minaga K, Yamashita Y, Ogura T, Takenaka M, Shimokawa Y, Hisa T, Itonaga M, Kato H, Nishikiori H, Okuda A, Matsumoto H, Uenoyama Y, Watanabe T, Chiba Y, Higuchi K, Kudo M, Kitano M.
Dig Endosc. 2019 Mar;31(2):180-187. doi: 10.1111/den.13242. Epub 2018 Aug 27.

Comparison of the efficacy and safety of endoscopic ultrasound-guided choledochoduodenostomy and hepaticogastrostomy for malignant distal biliary obstruction: Multicenter, randomized, clinical trial.
Minaga K, Ogura T, Shiomi H, Imai H, Hoki N, Takenaka M, Nishikiori H, Yamashita Y, Hisa T, Kato H, Kamada H, Okuda A, Sagami R, Hashimoto H, Higuchi K, Chiba Y, Kudo M, Kitano M.
Dig Endosc. 2019 Sep;31(5):575-582. doi: 10.1111/den.13406. Epub 2019 May 29.

（日赤　上尾先生より）
原著論文(英文原著)
Wada K, Ueo T, Yonemasu H, Togo K, Inoue S, Honda H, Katsuta M, Takahashi H, Yao K, Murakami K. Antacids may increase the appearance of white opaque substance in Helicobacter pylori -eradicated gastric epithelial neoplasia. Endosc Int Open. 2019;7(9):E1144-E1149.
赤田純子，Tshibangu Evariste Kabamba，内田智久，沖本忠義, 水上一弘，兒玉雅明，村上和成，山岡𠮷生
Award Report(上原H. pylori優秀賞)
ラテックス凝集免疫比濁法によるアジア7か国のH. pylori血清抗体価の比較解析
日本ヘリコバクター学会誌, 20(2), 71-73, 2019.1
村上和成
Ⅲ消化管疾患　B.　胃・十二指腸　
慢性胃炎
消化器疾患　最新の治療　2019-2020, 129-132, 2019.3

村上和成
H.pylori除菌治療の現状と展望
The GI Forefront, 14(2), 23, 2019.3

上尾哲也,、高橋晴彦、八尾建史、米増博俊、村上和成　原著論文（和文原著）
胃上皮性腫瘍の拡大内視鏡診断体系(MESDA-G)と読影法
胃と腸, 54(2), 191-200, 2019.2

本田秀穂、上尾哲也、米増博俊、福田昌英、渕野貴文、高橋晴彦、都甲和美、勝田真琴、木本喬博、安部雄治、井上翔太郎、和田蔵人、九嶋亮治、村上和成
Light blue crest陽性の小腸型低胃型度分化型胃癌（狭義の横這型胃癌）の1例
胃と腸、54(2), 273-277, 2019.2

清家正隆
【NAFLDとNASHの現況と展望-国民病となったNAFLD/NASHの疾患概念の変遷と問題点】 NAFLD/NASH　メタボリック症候群の肝病変として・肝疾患の予後
カレントテラピー, 37(1), 78-83, 2019

沖本忠義、村上和成
高齢者に対するヘリコバクター・ピロリ除菌
Geriatric Medicine 〈老年医学〉, 57(6), 557-560, 2019.6

沖本忠義
ACG2018 (American College of Gastroenterology) 2018年10月5日～10日、Philadelphia, USA
Helicobacter Research, 23(1), 65-66, 2019.5

村上和成
腸内細菌の検査法
内科学書（改訂第９版）, vol.4, 77-78, 2019.8

遠藤美月、清家正隆
糖尿病合併NAFLD/NASH診療―糖尿病内科と肝臓内科の連携＿肝臓内科のサイドから＿
肝臓クリニカルアップデート, Vol.5 (2)183-187, 2019.10

沖本忠義、村上和成
除菌後の胃粘膜
消化器内科, vo1.1(1)64-70,2019.12

兒玉雅明、村上和成
胃がんとピロリ菌感染
胃がんリスク層別化健診 (ABC健診)　第1版　2019.11

村上和成
新たな専門医制度とは
消化器のひろば　No.15, 2019.9

木下慶亮、園田光、福地聡士、梶本展明、新関修、山下勉、岡本和久、室豊吉、村上和成
急性膵炎にて発症した十二指腸原発濾胞性悪性リンパ腫の1例
Gastrotenterological Endoscopy Vol.61(8).1576-1581, Aug 2019.

清家正隆
肝性脳症治療の最近の考え方　非吸収性合成二糖類(解説/特集)
肝・胆・膵 (0389-4991) vol.78(3) 385-389, Mar, 2019.

大谷 直由, 梅木 健二, 安東 優, 小野 麻美, 徳丸 治, 兒玉 雅明, 倉成 正恵, 橋永 一彦, 宇佐川 佑子, 後藤 昭彦, 松本 紘幸, 皆尺寺 いずみ, 小野 朋子, 本城 心, 小宮 幸作, 森 宣, 佐々木 啓徳, 木曽 達也, 蓮沼 智子, 今井 浩光, 嶋田 顕, 上村 尚人, 門田 淳一
ゲフィチニブ錠250mg「サワイ」の健康成人における生物学的同等性試験(原著論文)
新薬と臨牀 (0559-8672)　Vol.68(5). 624-637 May,2019.

柴田 智隆, 武内 裕, 松成 修, 鍋田 祐介, 猪股 雅史, 坂本 照夫
腹部外傷診療体制の構築をめざして(解説/特集)
日本腹部救急医学会雑誌　vol.39(5), 855-858, July, 2019.

井上 貴子, 是永 匡紹, 井上 淳, 本田 浩一, 近藤 泰輝, 的野 智光, 榎本 大, 松波 加代子, 飯尾 悦子, 松浦 健太郎, 藤原 圭, 野尻 俊輔, 田中 靖人
非肝臓専門医へのデプスインタビューに基づく当院での「肝炎用診療情報提供書」運用による成果(原著論文)
肝臓 vol.60(7), 219-228, July 2019.

和田 康宏, 九嶋 亮治
胃　胃癌　菅野・中村の分類(解説/特集)
胃と腸 vol.54(5) 650-651, May, 2019.

兒玉雅明、沖本忠義、水上一弘、小川竜、岡本和久、村上和成
除菌後胃粘膜所見の経時的変化
臨牀消化器内科　Vol.34,No13(5),2019.12

沖本忠義．十二指腸潰瘍．消化管症候群（第3版）Ⅰ　－その他の消化管疾患を含めて－　Ⅱ十二指腸．別冊日本臨牀　領域別症候群シリーズ　№９ 2019, 401-407

兒玉雅明、沖本忠義、水上一弘、村上和成. びらん性胃炎. 消化管症候群（第3版）Ⅰ　－その他の消化管疾患を含めて－　I胃. 別冊日本臨牀　領域別症候群シリーズ №９ 2019, 80-84

堤康志郎、加藤元彦．十二指腸非上皮性腫瘍. 消化管症候群（第3版）Ⅰ　－その他の消化管疾患を含めて－　Ⅱ十二指腸．別冊日本臨牀　領域別症候群シリーズ　№９ 2019, 438-441

兒玉雅明. ヘリコバクターピロリ感染症　－最近の話題と問題点-. 令和元年度第49回九州地区大学保健管理研究協議会報告書 49: 23-25, 2019.

原著論文(和文原著)
本田秀穂、上尾哲也、 米増博俊、 福田昌英、渕野貴文,、高橋晴彦、都甲和美、勝田真琴、木本喬博、安部雄治、井上翔太郎、和田蔵人、九嶋亮治、村上和成
Light blue crest陽性の小腸型低異型度分化型胃癌（狭義の横這型胃癌）の１例.
胃と腸, 54(2), 273-277.

勝田真琴、上尾哲也、高橋晴彦、米増博俊、福田昌英、石飛裕和、九嶋亮治、村上和成
制酸薬投与によりNBI拡大所見が変化した除菌後発見低異型度分化型胃癌の1例．
臨牀消化器内科，35(2)，219-225.